(atoltivimab + maftivimab + odesivimab)
Marketedupdated 2mo agoby $REGN REGENERON PHARMACEUTICALS, INC.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
nothing on the calendar yet
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that